Segui
Peter D.R. Higgins
Peter D.R. Higgins
Professor of Gastroenterology, Internal Medicine, University of Michigan
Email verificata su umich.edu - Home page
Titolo
Citata da
Citata da
Anno
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
W Hueber, BE Sands, S Lewitzky, M Vandemeulebroecke, W Reinisch, ...
Gut 61 (12), 1693-1700, 2012
15252012
Epidemiology of constipation in North America: a systematic review
PDR Higgins, JF Johanson
Official journal of the American College of Gastroenterology| ACG 99 (4 …, 2004
14752004
Statins and the risk of colorectal cancer
JN Poynter, SB Gruber, PDR Higgins, R Almog, JD Bonner, HS Rennert, ...
New England Journal of Medicine 352 (21), 2184-2192, 2005
9922005
Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis
A Singal, ML Volk, A Waljee, R Salgia, P Higgins, MAM Rogers, ...
Alimentary pharmacology & therapeutics 30 (1), 37-47, 2009
9372009
Statins and cancer prevention
MF Demierre, PDR Higgins, SB Gruber, E Hawk, SM Lippman
Nature Reviews Cancer 5 (12), 930-942, 2005
9342005
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis
BJ Elmunzer, JM Scheiman, GA Lehman, A Chak, P Mosler, PDR Higgins, ...
New England Journal of Medicine 366 (15), 1414-1422, 2012
8542012
A primer on effectiveness and efficacy trials
AG Singal, PDR Higgins, AK Waljee
Clinical and translational gastroenterology 5 (1), e45, 2014
7522014
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to …
GR D'haens, R Panaccione, PDR Higgins, S Vermeire, M Gassull, ...
Official journal of the American College of Gastroenterology| ACG 106 (2 …, 2011
5442011
European evidence-based consensus: inflammatory bowel disease and malignancies
V Annese, L Beaugerie, L Egan, L Biancone, C Bolling, C Brandts, ...
Journal of Crohn's and Colitis 9 (11), 945-965, 2015
4452015
Association of host genome with intestinal microbial composition in a large healthy cohort
W Turpin, O Espin-Garcia, W Xu, MS Silverberg, D Kevans, MI Smith, ...
Nature genetics 48 (11), 1413-1417, 2016
4422016
The human gut microbiome: current knowledge, challenges, and future directions
M Dave, PD Higgins, S Middha, KP Rioux
Translational Research 160 (4), 246-257, 2012
4332012
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
A Waljee, J Waljee, AM Morris, PDR Higgins
Gut 55 (11), 1575-1580, 2006
4142006
Comparison of imputation methods for missing laboratory data in medicine
AK Waljee, A Mukherjee, AG Singal, Y Zhang, J Warren, U Balis, ...
BMJ open 3 (8), e002847, 2013
4082013
A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis
BJ Elmunzer, AK Waljee, GH Elta, JR Taylor, SMA Fehmi, PDR Higgins
Gut 57 (9), 1262-1267, 2008
4062008
The epidemiology of ischaemic colitis
PDR Higgins, KJ Davis, L Laine
Alimentary pharmacology & therapeutics 19 (7), 729-738, 2004
3522004
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
J Panés, WJ Sandborn, S Schreiber, BE Sands, S Vermeire, G D'Haens, ...
Gut 66 (6), 1049-1059, 2017
3492017
Empiric Quadruple vs. Triple Therapy for Primary Treatment ofHelicobacter pyloriInfection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
J Luther, PDR Higgins, PS Schoenfeld, P Moayyedi, N Vakil, WD Chey
Official journal of the American College of Gastroenterology| ACG 105 (1), 65-73, 2010
3142010
Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection
M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ...
Gastroenterology 150 (7), 1568-1578, 2016
3092016
Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature
J Luther, M Dave, PDR Higgins, JY Kao
Inflammatory bowel diseases 16 (6), 1077-1084, 2010
3002010
Efficacy and safety of MEDI2070, an antibody against interleukin 23, in patients with moderate to severe Crohn’s disease: a phase 2a study
BE Sands, J Chen, BG Feagan, M Penney, WA Rees, S Danese, ...
Gastroenterology 153 (1), 77-86. e6, 2017
2872017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20